Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial

Lancet

Volumn 353, Issue 9152, 1999, Pages 525-535

  Wawer, Maria J ^a,d   Sewankambo, Nelson K ^b   Serwadda, David ^b   Quinn, Thomas C ^e   Paxton, Lynn A ^a   Kiwanuka, Noah ^c   Wabwire Mangen, Fred ^b   Li, Chuanjun ^e   Lutalo, Thomas ^c   Nalugoda, Fred ^c   Gaydos, Charlotte A ^e   Moulton, Lawrence H ^e   Meehan, Mary O ^a   Ahmed, Saifuddin ^e   Gray, Ronald H ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^d Columbia Univ Sch of Public Health ^*  (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; METRONIDAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; UGANDA; VAGINITIS;

EID: 0032994454     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)06439-3     Document Type: Article

References (36)

1. Wasserheit JN. Epidemiologic synergy: interrelationsips between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 9: 2565-69.
2. Laga M, Manoka A, Kivuvu M, et al. Non ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7: 95-102.
3. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998; 351 (suppl III): 5-7.
4. Cohen MA, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349: 1868-73.
5. Ghys PD, Fransen K, Diallo MO, et al. The association between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997; 11: F85-93.
6. Mertens TE, Hayes RJ, Smith PG. Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS 1990; 4: 57-65.
7. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in Tanzania: randomised, controlled trial. Lancet 1995; 346: 530-36.
8. Hayes R, Grosskurth H, Ka-Gina G. Impact of improved treatment of sexually transmitted disease on HIV infection. Lancet 1995; 346: 1159-60.
9. Mayaud P, Mosha F, Todd J, et al. Improved treatment services significantly reduce the prevalence of sexualy transmitted diseases in rural Tanzania: results of a randomised controlled trial. AIDS 1997; 11: 1873-80.
10. Serwadda D, Wawer MJ, Musgrave SD, Sewankambo NK, Kaplan JE, Gray RH. HIV risk factors in three geographic strata of rural Rakai district, Uganda. AIDS 1992; 6: 983-89.
11. Wawer MJ, Sewankambo NK, Berkley S, et al. Incidence of HIV-1 infection in a rural region of Uganda. BMJ 1994; 308: 171-73.
12. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized, community-based trial of intense sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 1998; 12: 1211-25.
13. Hayes R, Wawer M, Gray R, et al. Randomised trials of STD treatment of HIV prevention: report of an international workshop. Genitourin Med 1997; 73: 432-43.
14. Gray RH, Kigozi G, Wabwire-Manger F, et al. A randomized trials of STD control during pregnancy in Rakai, Uganda: impact on maternal and infant health. 12th World AIDS Conference, Geneva, June 28-3 July, 1998: abstr 528-23276.
15. Sanchez-Martinez D, Schmid S, Whittington W, et al. Evaluation of a test based on baculovirus-expressed glycoprotein for detection of herpes simplex virus type-specific antibodies. J Infect Dis 1991; 164: 1196-99.
16. Buimer M, Van Doornum GJ, Ching S, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening. J Clin Microbiol 1996; 34: 2395-400.
17. Lee HH Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995; 345: 213-16.
18. Urnowitz HB, Stturge JC, Gottfried TD, Increased sensitivity of HIV-1 antibody detection. Nat Med 1997; 3: 1258.
19. Nugent RP, Krohn MA, Hillier S. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.
20. Orle KA, Gates CA, Martin DH, Body BA, Weiss JB. Simultaneous PCR detction of Haemophilus ducreyi, Treponema pallidum and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol 1996; 34: 49-54.
21. Sweet RL. New approaches for the treatment of bacterial vaginosis. Am J Obstet Gynecol 1993; 169: 479-82.
22. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnency: a meta-analysis. Am J Obstet Gynecol 1995; 172: 525-29.
23. Center For Disease Control and Prevention: CDC Sexually Transmitted Disease Treatment Guidelines. MMWR Morbid Mortal Weekly Rep 1993; 43: 1-102.
24. Hayes R, Mosha F, Nicoll A, et al. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1 design. AIDS 1995; 9: 919-26.
25. Brookmyer R, Chen YQ. Person-time analysis of paired community intervention trials when the number of communities is small. Stat Med 1998; 17: 2121-32.
26. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Public Health 1998; 88: 15-19.
27. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
28. Serwadda D, Gray RH, Wawer MJ, et al. The social dynamics of HIV transmission as reflected through discordant couples in rural Uganda. AIDS 1995; 9: 745-50.
29. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350: 546-50.
30. Taha E, Kumwenda N, Liomba GN, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998; 12: 1699-706.
31. Robinson NJ, Mulder DW, Auvert B, Hayes R. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates. Int J Epidemiol 1997; 26: 180-88.
32. Gray RH, Serwadda D, Wawer MJ, et al. Treatable STDs account for a modest proportion of HIV acquisition in a population-based study: relative and attributable risk estimates from Rakai, Uganda. 12th World AIDS Conference, Geneva, June 28-July 2, 1998: abstr 23602: p 21.
33. Wawer MJ, Sewankambo NK, Seradda D, et al. Population attributable risk of HIV incidence associated with STD symptoms, Rakai community-based study, Uganda. 12th World AIDS Conference, Geneva, June 28-July 3, 1998: abstr 524/23372.
34. Paxton L, Sewankambo NS, Wawer MJ, et al. Asymptomatic genital tract infections in a rural district of Uganda. 11th International Conference on AIDS, Vancouver, July 7-12, 1996: abstr C340:37.
35. Grosskurth H, Mayaud P, Mosha F, et al. Asymptomatic gonorrhoea and chlamydia infection in rural Tanzanian men. BMJ 1996; 312: 277-90.
36. Dellabetta GA, Gerbase AL, Holmes KK. Problems, solutions and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect 1998; 74: (suppl 1): S1-11.